Although none of the 20 primary GBM cell lines tested carried the constitutively active EGFRvIII mutant, EGFR gene amplification, a hallmark genetic aberration in GBMs, occurred in almost all of them, expressing varying levels of the EGFR. The gene discussed is EGFR; the disease is glioblastoma.